Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005855
Status:
COMPLETED
Last Update Posted:
2013-06-21
First Post:
2000-06-02
Brief Title:
Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
Sponsor:
New Approaches to Brain Tumor Therapy Consortium
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000067881
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
New Approaches to Brain Tumor Therapy Consortium
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |